These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 33583102)

  • 21. A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects.
    Taylor L; Gidal B; Blakey G; Tayo B; Morrison G
    CNS Drugs; 2018 Nov; 32(11):1053-1067. PubMed ID: 30374683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential.
    White CM
    J Clin Pharmacol; 2019 Jul; 59(7):923-934. PubMed ID: 30730563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Precipitation complexation method produces cannabidiol/beta-cyclodextrin inclusion complex suitable for sublingual administration of cannabidiol.
    Mannila J; Järvinen T; Järvinen K; Jarho P
    J Pharm Sci; 2007 Feb; 96(2):312-9. PubMed ID: 17051591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population Pharmacokinetics of Oral-Based Administration of Cannabidiol in Healthy Adults: Implications for Drug Development.
    Schultz HB; Hosseini A; McLachlan AJ; Reuter SE
    Cannabis Cannabinoid Res; 2023 Oct; 8(5):877-886. PubMed ID: 35443784
    [No Abstract]   [Full Text] [Related]  

  • 25. Cannabidiol Bioavailability Is Nonmonotonic with a Long Terminal Elimination Half-Life: A Pharmacokinetic Modeling-Based Analysis.
    Kolli AR; Hoeng J
    Cannabis Cannabinoid Res; 2024 Apr; ():. PubMed ID: 38624257
    [No Abstract]   [Full Text] [Related]  

  • 26. Examination of a New Delivery Approach for Oral Cannabidiol in Healthy Subjects: A Randomized, Double-Blinded, Placebo-Controlled Pharmacokinetics Study.
    Patrician A; Versic-Bratincevic M; Mijacika T; Banic I; Marendic M; Sutlović D; Dujić Ž; Ainslie PN
    Adv Ther; 2019 Nov; 36(11):3196-3210. PubMed ID: 31512143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of cannabidiol following single oral and oral transmucosal administration in dogs.
    Della Rocca G; Paoletti F; Conti MB; Galarini R; Chiaradia E; Sforna M; Dall'Aglio C; Polisca A; Di Salvo A
    Front Vet Sci; 2022; 9():1104152. PubMed ID: 36686155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of Sativex® in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders.
    Fernández-Trapero M; Pérez-Díaz C; Espejo-Porras F; de Lago E; Fernández-Ruiz J
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32054131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and effects on arachidonic acid metabolism of low doses of cannabidiol following oral administration to horses.
    Ryan D; McKemie DS; Kass PH; Puschner B; Knych HK
    Drug Test Anal; 2021 Jul; 13(7):1305-1317. PubMed ID: 33723919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of cannabidiol in a randomized crossover trial in senior horses.
    Turner SE; Knych HK; Adams AA
    Am J Vet Res; 2022 Jul; 83(9):. PubMed ID: 35895770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sodium alginate microencapsulation improves the short-term oral bioavailability of cannabidiol when administered with deoxycholic acid.
    Majimbi M; Brook E; Galettis P; Eden E; Al-Salami H; Mooranian A; Al-Sallami H; Lam V; Mamo JCL; Takechi R
    PLoS One; 2021; 16(6):e0243858. PubMed ID: 34138862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PTL401, a New Formulation Based on Pro-Nano Dispersion Technology, Improves Oral Cannabinoids Bioavailability in Healthy Volunteers.
    Atsmon J; Cherniakov I; Izgelov D; Hoffman A; Domb AJ; Deutsch L; Deutsch F; Heffetz D; Sacks H
    J Pharm Sci; 2018 May; 107(5):1423-1429. PubMed ID: 29287930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs.
    Bartner LR; McGrath S; Rao S; Hyatt LK; Wittenburg LA
    Can J Vet Res; 2018 Jul; 82(3):178-183. PubMed ID: 30026641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabidiol or CBD Oil: Help, Hope, and Hype for Psychiatric and Neurologic Conditions.
    Newton M; Newton DW
    J Am Psychiatr Nurses Assoc; 2020; 26(5):447-457. PubMed ID: 32508204
    [No Abstract]   [Full Text] [Related]  

  • 35. Preclinical Assessment of the Abuse Potential of Purified Botanical Cannabidiol: Self-Administration, Drug Discrimination, and Physical Dependence.
    Gray RA; Heal DJ; Maguire DR; Gerak LR; Javors MA; Smith S; France CP
    J Pharmacol Exp Ther; 2022 Jul; 382(1):54-65. PubMed ID: 35489780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of cannabichromene in a medical cannabis product also containing cannabidiol and Δ
    Peters EN; MacNair L; Mosesova I; Christians U; Sempio C; Klawitter J; Land MH; Ware MA; Turcotte C; Bonn-Miller MO
    Eur J Clin Pharmacol; 2022 Feb; 78(2):259-265. PubMed ID: 34664109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of Oil-in-Water Cannabidiol Emulsion for the Treatment of Rheumatoid Arthritis.
    Jelínek P; Roušarová J; Ryšánek P; Ježková M; Havlůjová T; Pozniak J; Kozlík P; Křížek T; Kučera T; Šíma M; Slanař O; Šoóš M
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):147-159. PubMed ID: 36342775
    [No Abstract]   [Full Text] [Related]  

  • 38. Enhanced Intramuscular Bioavailability of Cannabidiol Using Nanocrystals: Formulation, In Vitro Appraisal, and Pharmacokinetics.
    Fu X; Xu S; Li Z; Chen K; Fan H; Wang Y; Xie Z; Kou L; Zhang S
    AAPS PharmSciTech; 2022 Mar; 23(3):85. PubMed ID: 35288801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions.
    Anderson LL; Absalom NL; Abelev SV; Low IK; Doohan PT; Martin LJ; Chebib M; McGregor IS; Arnold JC
    Epilepsia; 2019 Nov; 60(11):2224-2234. PubMed ID: 31625159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial.
    Schoedel KA; Szeto I; Setnik B; Sellers EM; Levy-Cooperman N; Mills C; Etges T; Sommerville K
    Epilepsy Behav; 2018 Nov; 88():162-171. PubMed ID: 30286443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.